KR920701192A - 치환 이소플라본 유도체의 개량된 제조방법 - Google Patents

치환 이소플라본 유도체의 개량된 제조방법

Info

Publication number
KR920701192A
KR920701192A KR1019910701792A KR910701792A KR920701192A KR 920701192 A KR920701192 A KR 920701192A KR 1019910701792 A KR1019910701792 A KR 1019910701792A KR 910701792 A KR910701792 A KR 910701792A KR 920701192 A KR920701192 A KR 920701192A
Authority
KR
South Korea
Prior art keywords
formula
degrees
general formula
reaction
cyclization
Prior art date
Application number
KR1019910701792A
Other languages
English (en)
Other versions
KR0149172B1 (ko
Inventor
타마스 칼라이
기요르기 라니이
라스즐로 레드니크즈키
라조스 임레이
기요르기 호프만
마리아 스질라디
에바 솜파이
티보르 몬타이
Original Assignee
기율라스주크, 타마스스주츠
치노인 교기스져 에스베게스제티 테르메케크 기야라 알티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 기율라스주크, 타마스스주츠, 치노인 교기스져 에스베게스제티 테르메케크 기야라 알티 filed Critical 기율라스주크, 타마스스주츠
Publication of KR920701192A publication Critical patent/KR920701192A/ko
Application granted granted Critical
Publication of KR0149172B1 publication Critical patent/KR0149172B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

내용 없음

Description

치환ㆍ이소플라본 유도체의 개량된 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 다음 일반 구조식(Ⅳ)의 레조르시놀 유도체를
    식중 R2및 R3는 수소 또는 탄소수 1-2의 알콕시기이다.
    다음 구조식(Ⅳ)의 에틸 오르토포르메이트와
    (C2H5O)3CH (Ⅳ)
    염기의 존재하에 70-100도의 온도에서, 레조르시놀 유도체 사용량 기준으로 0.3-2배량의 유기 용매, 바람직하게는 디메틸포름아마이드, 이소프로판을 또는 디메틸로름아마이드와 이소프로판올의 혼합용매의 존재하에 반응시키거나 또는 과량의 구조식(Ⅳ)의 화합물을 존재하에 환화반응시켜서 다음 일반구조식(Ⅷ)의 화합물의 20-70%중량의 과포화 용액을 제조하고,
    식중 R2및 R3는 전술한 바와같다. 반응용액을 냉각시킨후 계속해서 침전시킨후 여과하거나; 또는 반응용액에 극성 또는 비극성 용매을 가하여 부생물을 선택적으로 용해시키고 일반 구조식(Ⅶ)의 화합물의 침전을 여과시키거나; 또는 반응혼합물에 거의 같은 몰량의 무수 탄산칼륨을 가하고 생성된 다음 일반 구조식(Ⅴ)의 결정성 복염을 분리하고
    식중 R2및 R3는 전술한 바와같다. 얻어진 상기 일반 구조식(Ⅴ) 또는 (Ⅶ)의생성물을 이소프로필 할라이드와 반응시키고 분리함을 특징으로 하는 다음 일반 구조식(Ⅵ)의 오염물질을 0.5%중량이하로 함유하는 것을 특징으로 하는 다음 일반 구조식(Ⅰ)의
    식중 R은 수소원자 또는 이소프로필기이며, R2및 R3는 전술한 바와 같다. 순수한 이소플라본 유도체를 제조하는 방법.
  2. 제1항에서 환화반응을 열처리를 행하여 80-90도의 온도에서 4-10시간동안 행하는 방법.
  3. 제1-2항에서 환화반응에서 생성된 에탄올을 저류시킴을 특징으로 하는 방법.
  4. 제1-3항에서 비극성 용매, 바람직하게는 톨루엔을 반응혼합물에 가하고 무수탄산칼륨을 40-80도, 바람직하게는 60도에서 가한 후에 복염을 형성시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
KR1019910701792A 1990-04-06 1990-04-06 치환 이소플라본 유도체의 개량된 제조방법 KR0149172B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1990/000023 WO1991015483A1 (en) 1990-04-06 1990-04-06 An improved process for the preparation of substituted isoflavone derivatives

Publications (2)

Publication Number Publication Date
KR920701192A true KR920701192A (ko) 1992-08-11
KR0149172B1 KR0149172B1 (ko) 1998-10-15

Family

ID=10980899

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701792A KR0149172B1 (ko) 1990-04-06 1990-04-06 치환 이소플라본 유도체의 개량된 제조방법

Country Status (15)

Country Link
US (1) US5247102A (ko)
EP (1) EP0478558B1 (ko)
JP (1) JPH089610B2 (ko)
KR (1) KR0149172B1 (ko)
AT (1) ATE101143T1 (ko)
AU (1) AU631860B2 (ko)
CA (1) CA2058619C (ko)
DE (1) DE69006502T2 (ko)
DK (1) DK0478558T3 (ko)
FI (1) FI915741A0 (ko)
HK (1) HK1003995A1 (ko)
LT (1) LT3463B (ko)
NO (1) NO300733B1 (ko)
RU (1) RU2036918C1 (ko)
WO (1) WO1991015483A1 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002603A (en) * 1989-12-04 1991-03-26 Board Of Trustees Operating Michigan State University Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
US5204369A (en) * 1991-07-01 1993-04-20 The Endowment For Research In Human Biology Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
EP0656786B2 (en) 1992-05-19 2014-04-23 Novogen Research Pty Ltd Use of isoflavone phyto-oestrogen extracts of soy or clover
HUT68558A (en) * 1993-07-20 1995-06-28 Chinoin Gyogyszer Es Vegyeszet Method for preparing isoflavon derivatives
US5670632A (en) * 1996-01-18 1997-09-23 Acds Technologies, Ltd. Process for obtaining an isoflavone concentrate from a soybean extract
AUPO203996A0 (en) * 1996-08-30 1996-09-26 Novogen Research Pty Ltd Therapeutic uses
US6146668A (en) 1997-04-28 2000-11-14 Novogen, Inc. Preparation of isoflavones from legumes
US6255497B1 (en) 1997-04-29 2001-07-03 The Endowment For Research In Human Biology, Inc. Method for the inhibition of ALDH-I useful in the treatment of alcohol dependence or alcohol abuse
EP0979074A4 (en) * 1997-05-01 2003-07-09 Novogen Inc TREATMENT OR PREVENTION CLIMATE ACTION SYMPTOMS AND OSTEOPOROSIS
AUPP112497A0 (en) * 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
IT1298619B1 (it) * 1998-03-10 2000-01-12 Erregierre Spa Processo di preparazione dell'epriflavone
AUPP260798A0 (en) * 1998-03-26 1998-04-23 Novogen Research Pty Ltd Treatment of medical related conditions with isoflavone containing extracts of clover
AUPQ266199A0 (en) * 1999-09-06 1999-09-30 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
US20090233999A1 (en) * 1999-09-06 2009-09-17 Novogen Research Pty Ltd Compositions and therapeutic methods involving isoflavones and analogues thereof
AUPQ520300A0 (en) * 2000-01-21 2000-02-17 Novogen Research Pty Ltd Food product and process
AUPR363301A0 (en) * 2001-03-08 2001-04-05 Novogen Research Pty Ltd Dimeric isoflavones
US20050119301A1 (en) * 2001-03-16 2005-06-02 Alan Husband Treatment of restenosis
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
CA2491089A1 (en) 2002-06-27 2004-01-08 The Endowment For Research In Human Biology, Inc. Compounds useful for the inhibition of aldh
AU2003255232A1 (en) 2002-08-07 2004-02-25 University Of Mississippi Antigiardial agents and use thereof
US8158810B2 (en) 2006-07-27 2012-04-17 Gilead Sciences, Inc. ALDH-2 inhibitors in the treatment of addiction
TWI324514B (en) 2008-02-26 2010-05-11 Univ Kaohsiung Medical Isoflavone derivatives and pharmaceutical compositions comprising the same
TWI365071B (en) 2008-02-26 2012-06-01 Univ Kaohsiung Medical Isoxazole derivatives and pharmaceutical compositions comprising the same
CN103145673B (zh) * 2011-12-06 2015-05-20 安徽贝克生物制药有限公司 黄豆苷元衍生物及其药学上可接受的盐

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA201219A (en) 1920-06-22 Hippolyte Louis Sizaire Maurice Lubricating vehicle spring
CA193010A (en) 1919-04-02 1919-09-30 Alvin A. Ritcheson Motor vehicle
HU162377B (ko) * 1970-05-27 1973-02-28
GB1495305A (en) * 1975-09-12 1977-12-14 Pfizer Ltd 3-phenyl-4-oxo-4h-benzopyran derivatives
GB1495189A (en) * 1975-09-12 1977-12-14 Pfizer Ltd 4-oxo-4h-benzopyran derivatives and process for their preparation
JPS60132976A (ja) * 1983-12-21 1985-07-16 Takeda Chem Ind Ltd 新規３−フエニル−４ｈ−１−ベンゾピラン−４−オン誘導体
US4644012A (en) * 1983-12-21 1987-02-17 Takeda Chemical Industries, Ltd. Treatment for osteoporosis
US5002603A (en) * 1989-12-04 1991-03-26 Board Of Trustees Operating Michigan State University Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi

Also Published As

Publication number Publication date
DE69006502D1 (de) 1994-03-17
WO1991015483A1 (en) 1991-10-17
KR0149172B1 (ko) 1998-10-15
EP0478558A1 (en) 1992-04-08
CA2058619A1 (en) 1991-10-07
NO300733B1 (no) 1997-07-14
LT3463B (en) 1995-10-25
LTIP779A (en) 1995-01-31
HK1003995A1 (en) 1998-11-13
RU2036918C1 (ru) 1995-06-09
ATE101143T1 (de) 1994-02-15
AU5427490A (en) 1991-10-30
EP0478558B1 (en) 1994-02-02
US5247102A (en) 1993-09-21
CA2058619C (en) 1999-05-04
AU631860B2 (en) 1992-12-10
DK0478558T3 (da) 1994-05-02
NO914786D0 (no) 1991-12-05
JPH089610B2 (ja) 1996-01-31
NO914786L (no) 1991-12-05
JPH04507085A (ja) 1992-12-10
DE69006502T2 (de) 1994-05-19
FI915741A0 (fi) 1991-12-05

Similar Documents

Publication Publication Date Title
KR920701192A (ko) 치환 이소플라본 유도체의 개량된 제조방법
KR920010048B1 (ko) 광학 활성 피리도벤즈옥사진 유도체 및 이의 중간체의 제조방법
KR880006246A (ko) 레베카마이신 동족체
AU646055B2 (en) (6,7-substituted-8-alkoxy-1-cyclopropyl-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid-03,04)bis(acyloxy-0) borate and the salt thereof, and the preparing method of the same
EP0239476B1 (fr) Dérivés du pyridoindole, leur application à titre de médicaments et les compositions les renfermant
KR860001073A (ko) 이미다졸린의 제조방법
US4780537A (en) Pyrimidine derivatives and process preparing the same
PT80049B (pt) Processo para a preparacao de hidro-haletos de 2-hidrazino-1,3-diazacicloalquil-2-eno
KR870011134A (ko) 에트골린 에스테르 및 이의 제조방법
JPH0159273B2 (ko)
YU210886A (en) Process for obtaining norflosacine intermediary
KR920702671A (ko) 케톤화합물의 개량된 제조방법
KR880000429A (ko) T-부틸 에르골린 유도체
US2762804A (en) 3-methyl-5-phenyl-2, 6-piperazinedione and derivatives thereof and method of preparing same
US5162534A (en) Process for the preparation of thiazoline derivatives
CA2008751C (en) Organogermanium compounds, processes for producing the same and agent for inhibiting the activity of opioid peptide-degrading enzyme
Haasbroek et al. Structure of 2-acetoxy-3-(3-methoxy-4-acetoxy-5-chlorophenyl)-propenoic acid
PL166748B1 (pl) Sposób wytwarzania pochodnych 1 -alkilo-2-chlnolonu PL PL PL
JPS604830B2 (ja) フエニル酢酸誘導体
KR810000463B1 (ko) 치환 안식향산 아미드의 신규 제조방법
FR2579208A1 (fr) Nouveaux derives de le 5-h pyrido (3', 4' : 4,5) pyrrolo (3,2-c) pyridine, leur procede de preparation et leur activite antitumorale
KR930009817B1 (ko) 피리딘 유도체의 제조방법
KR860000296A (ko) 이소옥사졸로퀴롤리논 유도체의 제조방법
US2810727A (en) Process of producing n-acyl-tryptophan
KR810001695B1 (ko) 테레프탈산아미드 유도체의 제법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee